Benign epithelial lesions and benign tumors of the breast

1. Benign Epithelial Lesions

Overview

• Range from completely harmless to lesions with ↑ carcinoma risk.
• Some create palpable masses (stromal fibrosis).
• Consequence of exaggeration + distortion of normal cyclic breast changes during menstrual cycle.
• Divided into non-proliferative + proliferative.

A) Non-Proliferative Diseases (Fibrocystic Changes)

• Most common alteration.
• Characterized by:
  • ↑ Fibrous stroma
  • Dilation of ducts
  • Cyst formation (“blue dome cysts”)
• Stroma around cysts: compressed fibrous tissue (lost normal appearance).
• No ↑ risk of carcinoma.

B) Proliferative Diseases

Epithelial hyperplasia

• Ductal papillomatosis: papillary processes projecting into dilated cyst lumens.
• Atypical ductal hyperplasia (ADH) + Atypical lobular hyperplasia (ALH):
  • Resembles ductal/lobular CIS.
  • ↑ Risk of invasive carcinoma (4–5×).
• Epithelial hyperplasia usually does not produce a discrete mass.

Sclerosing adenosis

• Sclerosis = hardening; adenosis = enlargement of lobule with many acini.
• Proliferation of small ducts + ductules — masses of small gland patterns within fibrous stroma.
• Stroma compresses lumen of acini + ducts → appear as solid cords of cells.
• Difficult to distinguish from carcinoma clinically + histologically.
• Slightly ↑ risk of malignant transformation.

2. Benign Tumors of the Breast

A) Fibroadenoma

• Most common benign breast tumor.
• Estrogen-driven (↑ estrogen levels contribute to development).
• Small, solid, rubbery, non-cancerous, harmless lumps.
• Arises from CT (stroma) + epithelium.
• Usually young women, peak incidence in 3rd decade.

Clinical features

• Solitary movable mass (“breast mouse”).
• May enlarge in menstrual cycle / pregnancy → regress + calcify postmenopausally.
• Almost never become malignant.

B) Phyllodes Tumor

• Much less common; arise from periductal stroma.
• May exhibit leaf-like epithelial pattern (Greek: phyllo = leaf).
• ↑ Stromal cellularity + anaplasia + high mitotic activity.
• Accompanied by ↑ size + invasion of adjacent breast tissue by malignant stroma.
• Most remain localized → cured by wide excision.
• Only most malignant forms give distant metastasis.

C) Intraductal Papilloma

• Benign epithelial tumors growing in finger-like fronds within a duct.
• Most lesions are solitary; found in principal lactiferous ducts or sinuses.
• Clinical: serous or bloody nipple discharge.
• Solitary papilloma → almost always remain benign.
• Multiple papillomas (intraductal papillomatosis) → may become malignant.

3. Comparison Table

Lesion	Origin	Age	Key feature	Cancer risk
Fibrocystic change	Ducts + stroma	Reproductive	Cysts + fibrosis	None
Epithelial hyperplasia (atypical)	Ductal/lobular epithelium	Reproductive	Atypia	4–5× ↑
Sclerosing adenosis	Ducts + ductules	Reproductive	Solid cords mimicking carcinoma	Mild ↑
Fibroadenoma	CT + epithelium	Young (3rd decade)	Movable rubbery mass; estrogen-driven	Almost none
Phyllodes tumor	Periductal stroma	50s	Leaf-like pattern, large	Some malignant
Intraductal papilloma	Duct epithelium	Reproductive	Bloody nipple discharge	Solitary = benign; multiple = ↑

💡 High-yield: Fibrocystic change = #1 benign breast lesion (cysts + fibrosis + no ↑ cancer risk). Sclerosing adenosis = mimics carcinoma. Atypical ductal/lobular hyperplasia (ADH/ALH) = 4–5× ↑ cancer risk. Fibroadenoma = #1 benign breast tumor; young women, rubbery movable mass, estrogen-responsive, almost never malignant. Phyllodes tumor = periductal stroma, leaf-like pattern, mostly benign, rare distant metastasis. Intraductal papilloma = #1 cause of bloody nipple discharge (solitary = benign; multiple papillomatosis → ↑ malignancy).